-
1.
公开(公告)号:US20210017225A1
公开(公告)日:2021-01-21
申请号:US17061728
申请日:2020-10-02
申请人: Cytogel Pharma, LLC.
摘要: The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of peptides, and/or their salts, having advantageous μ-opioid receptor binding activity.
-
公开(公告)号:US11324798B2
公开(公告)日:2022-05-10
申请号:US16986802
申请日:2020-08-06
申请人: CYTOGEL PHARMA, LLC
摘要: The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.
-
公开(公告)号:US20140142050A1
公开(公告)日:2014-05-22
申请号:US14056496
申请日:2013-10-17
申请人: CYTOGEL PHARMA, LLC
发明人: THEODORE E MAIONE
IPC分类号: C07K5/10
CPC分类号: C07K5/1016 , A61K38/00 , C07K5/10
摘要: The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.
摘要翻译: 本发明提供了有利的mu-阿片受体肽的新盐。 已经发现,这些盐在它们的晶体结构,稳定性,溶解性,缺乏杂质和/或生产能力方面具有优异的性能,具有这些有利的性质,其用量足以制备治疗组合物。
-
公开(公告)号:US08092835B1
公开(公告)日:2012-01-10
申请号:US13269738
申请日:2011-10-10
申请人: Daqing Wu , Chih-Chang Chu , Joseph Carozza
发明人: Daqing Wu , Chih-Chang Chu , Joseph Carozza
IPC分类号: A61K9/14
CPC分类号: A61K9/0019 , A61K9/1647 , Y10T428/2982
摘要: Injectable microspheres are obtained from double bond functionalized polyhydric alcohol ester by a method comprising dissolving the double bond functionalized esters in a hydrophobic organic solvent, forming an aqueous solution of stabilizer, forming an oil in water emulsion where the solution of stabilizer constitutes the continuous phase and the solution of ester constitutes the disperse phase and evaporating the organic solvent or from block copolymer of PGCLM and methoxy poly(ethylene glycol).
摘要翻译: 可注射的微球体是通过将双键官能化的酯溶解在疏水性有机溶剂中,形成稳定剂的水溶液,形成稳定剂溶液形成连续相的水乳液的方法从双键官能化的多元醇酯得到的, 酯溶液构成分散相并蒸发有机溶剂或由PGCLM和甲氧基聚(乙二醇)的嵌段共聚物蒸发。
-
公开(公告)号:US12037416B2
公开(公告)日:2024-07-16
申请号:US16609840
申请日:2018-11-19
申请人: CYTOGEL PHARMA, LLC
CPC分类号: C07K7/06 , A61K47/542 , A61K47/60 , A61K47/61 , A61K47/62 , C07K5/1016 , A61K38/00
摘要: The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of polymers, and/or their salts, having advantageous μ-opioid receptor binding activity.
-
公开(公告)号:US20230212221A1
公开(公告)日:2023-07-06
申请号:US18146791
申请日:2022-12-27
申请人: Cytogel Pharma, LLC
发明人: Theodore E. MAIONE
IPC分类号: A61K38/07
CPC分类号: A61K38/07
摘要: The present invention pertains to novel uses of endomorphine-1 peptide, analogs, and salts thereof for therapy of children, patients currently suffering from drug addiction, patients prone to opioid addiction, and patients with chemo-induced pain.
-
7.
公开(公告)号:US10975121B2
公开(公告)日:2021-04-13
申请号:US15962200
申请日:2018-04-25
申请人: Cytogel Pharma, LLC
摘要: The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of peptides, and/or their salts, having advantageous μ-opioid receptor binding activity.
-
公开(公告)号:US08034383B2
公开(公告)日:2011-10-11
申请号:US13015193
申请日:2011-01-27
申请人: Daqing Wu , Chih-Chang Chu , Joseph Carozza
发明人: Daqing Wu , Chih-Chang Chu , Joseph Carozza
IPC分类号: A61K9/14
CPC分类号: A61K9/0019 , A61K9/1647 , Y10T428/2982
摘要: Injectable microspheres are obtained from double bond functionalized polyhydric alcohol ester by a method comprising dissolving the double bond functionalized esters in a hydrophobic organic solvent, forming an aqueous solution of stabilizer, forming an oil in water emulsion where the solution of stabilizer constitutes the continuous phase and the solution of ester constitutes the disperse phase and evaporating the organic solvent or from block copolymer of PGCLM and methoxy poly(ethylene glycol).
摘要翻译: 可注射的微球体是通过将双键官能化的酯溶解在疏水性有机溶剂中,形成稳定剂的水溶液,形成稳定剂溶液形成连续相的水乳液的方法从双键官能化的多元醇酯得到的, 酯溶液构成分散相并蒸发有机溶剂或由PGCLM和甲氧基聚(乙二醇)的嵌段共聚物蒸发。
-
9.
公开(公告)号:US11603385B2
公开(公告)日:2023-03-14
申请号:US17061728
申请日:2020-10-02
申请人: Cytogel Pharma, LLC.
摘要: The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of peptides, and/or their salts, having advantageous μ-opioid receptor binding activity.
-
公开(公告)号:US20220324908A1
公开(公告)日:2022-10-13
申请号:US17554421
申请日:2021-12-17
申请人: Cytogel Pharma, LLC
发明人: Theodore E. MAIONE
摘要: The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.
-
-
-
-
-
-
-
-
-